As the global economy mends, the 2021 growth of Commercializing Biomarkers in Therapeutic and Diagnostic Applications will have significant change from previous year. According to our (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size is USD million in 2022 from USD 20920 million in 2021, with a change of % between 2021 and 2022. The global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size will reach USD 29400 million in 2028, growing at a CAGR of 5.0% over the analysis period.
The United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market, reaching US$ million by the year 2028. As for the Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Commercializing Biomarkers in Therapeutic and Diagnostic Applications players cover Roche, Dako (Agilent Technologies), Merck, and BD, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Commercializing Biomarkers in Therapeutic and Diagnostic Applications market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Consumables
- Services
- Software
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
- Oncology
- Cardiology
- Neurology
- Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
- Roche
- Dako (Agilent Technologies)
- Merck
- BD
- Abbott
- Genesys Biolabs (20/20GeneSystems)
- Affymetrix
- Agendia
- ALMAC
- Arrayit
- Biocartic
- BG Medicine
- KEGG EXPRESSION Database
- Thermo Fisher
- BGI
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size 2017-2028
2.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Segment by Type
2.2.1 Consumables
2.2.2 Services
2.2.3 Software
2.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type
2.3.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Type (2017-2022)
2.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Neurology
2.4.4 Other
2.5 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application
2.5.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Application (2017-2022)
3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Player
3.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Players
3.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Players (2020-2022)
3.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Players (2020-2022)
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
4.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Regions (2017-2022)
4.2 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth (2017-2022)
4.3 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth (2017-2022)
4.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth (2017-2022)
4.5 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth (2017-2022)
5 Americas
5.1 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2017-2022)
5.2 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022)
5.3 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2017-2022)
6.2 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022)
6.3 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country (2017-2022)
7.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022)
7.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Region (2017-2022)
8.2 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022)
8.3 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Regions (2023-2028)
10.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Regions (2023-2028)
10.1.2 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast
10.1.3 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast
10.1.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast
10.1.5 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast
10.2 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Country (2023-2028)
10.2.1 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.2.2 Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.2.3 Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.2.4 Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.3 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Region (2023-2028)
10.3.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.3.2 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.3.3 Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.3.4 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.3.5 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.3.6 Australia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Country (2023-2028)
10.4.1 Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.4.2 France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.4.3 UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.4.4 Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.4.5 Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.5 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Region (2023-2028)
10.5.1 Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.5.2 South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.5.3 Israel Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.5.4 Turkey Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.5.5 GCC Countries Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
10.6 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Type (2023-2028)
10.7 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Dako (Agilent Technologies)
11.2.1 Dako (Agilent Technologies) Company Information
11.2.2 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Dako (Agilent Technologies) Main Business Overview
11.2.5 Dako (Agilent Technologies) Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Genesys Biolabs (20/20GeneSystems)
11.6.1 Genesys Biolabs (20/20GeneSystems) Company Information
11.6.2 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Genesys Biolabs (20/20GeneSystems) Main Business Overview
11.6.5 Genesys Biolabs (20/20GeneSystems) Latest Developments
11.7 Affymetrix
11.7.1 Affymetrix Company Information
11.7.2 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Affymetrix Main Business Overview
11.7.5 Affymetrix Latest Developments
11.8 Agendia
11.8.1 Agendia Company Information
11.8.2 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Agendia Main Business Overview
11.8.5 Agendia Latest Developments
11.9 ALMAC
11.9.1 ALMAC Company Information
11.9.2 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 ALMAC Main Business Overview
11.9.5 ALMAC Latest Developments
11.10 Arrayit
11.10.1 Arrayit Company Information
11.10.2 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Arrayit Main Business Overview
11.10.5 Arrayit Latest Developments
11. Biocartic
11.11.1 Biocartic Company Information
11.11.2 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.11.3 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Biocartic Main Business Overview
11.11.5 Biocartic Latest Developments
11.12 BG Medicine
11.12.1 BG Medicine Company Information
11.12.2 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.12.3 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 BG Medicine Main Business Overview
11.12.5 BG Medicine Latest Developments
11.13 KEGG EXPRESSION Database
11.13.1 KEGG EXPRESSION Database Company Information
11.13.2 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.13.3 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 KEGG EXPRESSION Database Main Business Overview
11.13.5 KEGG EXPRESSION Database Latest Developments
11.14 Thermo Fisher
11.14.1 Thermo Fisher Company Information
11.14.2 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.14.3 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Thermo Fisher Main Business Overview
11.14.5 Thermo Fisher Latest Developments
11.15 BGI
11.15.1 BGI Company Information
11.15.2 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
11.15.3 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 BGI Main Business Overview
11.15.5 BGI Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Consumables
Table 3. Major Players of Services
Table 4. Major Players of Software
Table 5. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Type (2017-2022)
Table 8. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Application (2017-2022)
Table 11. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Player (2020-2022)
Table 13. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Key Players Head office and Products Offered
Table 14. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Regions (2017-2022)
Table 19. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Country (2017-2022)
Table 21. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Type (2017-2022)
Table 23. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Application (2017-2022)
Table 25. APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Region (2017-2022)
Table 27. APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Type (2017-2022)
Table 29. APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Application (2017-2022)
Table 31. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Country (2017-2022)
Table 33. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Type (2017-2022)
Table 35. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table 44. Key Market Challenges & Risks of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table 45. Key Industry Trends of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table 46. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share Forecast by Application (2023-2028)
Table 52. Roche Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 53. Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 54. Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Dako (Agilent Technologies) Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 58. Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 59. Dako (Agilent Technologies) Main Business
Table 60. Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Dako (Agilent Technologies) Latest Developments
Table 62. Merck Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 63. Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 64. Merck Main Business
Table 65. Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Merck Latest Developments
Table 67. BD Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 68. BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 69. BD Main Business
Table 70. BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. BD Latest Developments
Table 72. Abbott Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 73. Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 74. Abbott Main Business
Table 75. Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Abbott Latest Developments
Table 77. Genesys Biolabs (20/20GeneSystems) Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 78. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 79. Genesys Biolabs (20/20GeneSystems) Main Business
Table 80. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Genesys Biolabs (20/20GeneSystems) Latest Developments
Table 82. Affymetrix Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 83. Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 84. Affymetrix Main Business
Table 85. Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Affymetrix Latest Developments
Table 87. Agendia Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 88. Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 89. Agendia Main Business
Table 90. Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Agendia Latest Developments
Table 92. ALMAC Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 93. ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 94. ALMAC Main Business
Table 95. ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. ALMAC Latest Developments
Table 97. Arrayit Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 98. Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 99. Arrayit Main Business
Table 100. Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Arrayit Latest Developments
Table 102. Biocartic Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 103. Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 104. Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Biocartic Main Business
Table 106. Biocartic Latest Developments
Table 107. BG Medicine Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 108. BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 109. BG Medicine Main Business
Table 110. BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. BG Medicine Latest Developments
Table 112. KEGG EXPRESSION Database Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 113. KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 114. KEGG EXPRESSION Database Main Business
Table 115. KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. KEGG EXPRESSION Database Latest Developments
Table 117. Thermo Fisher Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 118. Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 119. Thermo Fisher Main Business
Table 120. Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Thermo Fisher Latest Developments
Table 122. BGI Details, Company Type, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Area Served and Its Competitors
Table 123. BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
Table 124. BGI Main Business
Table 125. BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. BGI Latest Developments
List of Figures
Figure 1. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Type in 2021
Figure 7. Commercializing Biomarkers in Therapeutic and Diagnostic Applications in Oncology
Figure 8. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market: Oncology (2017-2022) & ($ Millions)
Figure 9. Commercializing Biomarkers in Therapeutic and Diagnostic Applications in Cardiology
Figure 10. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market: Cardiology (2017-2022) & ($ Millions)
Figure 11. Commercializing Biomarkers in Therapeutic and Diagnostic Applications in Neurology
Figure 12. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market: Neurology (2017-2022) & ($ Millions)
Figure 13. Commercializing Biomarkers in Therapeutic and Diagnostic Applications in Other
Figure 14. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Application in 2021
Figure 16. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Player in 2021
Figure 17. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size 2017-2022 ($ Millions)
Figure 19. APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size 2017-2022 ($ Millions)
Figure 20. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size 2017-2022 ($ Millions)
Figure 22. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value Market Share by Country in 2021
Figure 23. Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Market Share by Type in 2021
Figure 24. Americas Commercializing Bi
Global Biomarkers Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period.
The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 114
Market Overview of Global Biomarker (Medicine) market:
According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years.
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Commercializing Biom......
Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Biomarkers market:
According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
Global Biomarker Technology Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 86
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Laboratories
- Quanterix
- Bio-Rad Laboratories
- Epigenomics
- Agilent Technologies
- Johnson & Johnson
- Qiagen
- Roche Ho......
Global Renal Biomarkers Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 99
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Diagnostics
- F. Hoffmann-La Roche
- Beckman Coulter
- Siemens Healthcare Diagnostics
- Thermo Fisher Scientific
- Astute Medical
- Bio......
Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 114
Market Overview of Global Central Nervous System (CNS) Biomarkers market:
According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
An overview of the global market for central nervous system (CNS) biomarke......
Global Cancer Biomarker Market Research Report 2023
Published: 13-Nov-2023 Price: US 2900 Onwards Pages: 109
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Roche Diagnostics
- Qiagen
- Illumina
- GE Healthcare
- Agilent Technologies
- Biomér......
Biomarker Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 300
Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
